Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
- EUR | -.--% | +0.14% | +29.68% |
2023 | Nestle Reportedly May Sell Peanut Allergy Therapy to Stallergenes | CI |
2023 | Stallergenes Greer Ltd Initiates European Paediatric Phase III Study with Staloral Birch | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe1st Jan change | Capi. | |
---|---|---|
+29.68% | 0 | |
+17.28% | 79.38B | |
+9.28% | 8.74B | |
-14.24% | 4.94B | |
+49.95% | 4.7B | |
+5.96% | 3.98B | |
+11.81% | 2.28B | |
-23.57% | 2.28B | |
+17.77% | 2.14B | |
-32.28% | 2.12B |
- Stock Market
- Equities
- STAGR Stock
- News Stallergenes Greer
- Transcript : Stallergenes Greer Plc, H2 2017 Earnings Call, Mar 22, 2018